Has Ryan Smedley received payments from drug or device companies?

Yes. Drug and device makers reported $88,172 in general payments to Ryan Smedley across 237 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ryan Smedley did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ryan Smedley come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ryan Smedley

Corneal and Contact Management · Westminster, CONPI 1194936401

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (54.6%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Coopervision Inc. accounts for 97.3% of it on its own, with 9 other manufacturers making up the rest. 2025 is the largest year on record at $29,181, more than ten times the $214 reported in 2019. Among corneal and contact management clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$88,172in general payments, 2019–2025

Across 237 payments — averaging $372.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Coopervision Inc.$86K
Alcon$1K
Bausch & Lomb Americas Inc.$345
Johnson & Johnson Vision Care, Inc.$226
Biotissue Holdings Inc.$135
Bausch & Lomb, A Division Of Bausch Health US, LLC$107
plus $213 from 4 others

What the payments were for

Consulting fees$2,2803%
Speaking & faculty fees$48,15555%
Travel & lodging$29,68334%
Food & beverage$8,0379%
Gifts$170%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Coopervision Inc.	153	$85,815
Alcon	58	$1,329
Bausch & Lomb Americas Inc.	7	$345
Johnson & Johnson Vision Care, Inc.	11	$226
Biotissue Holdings Inc.	2	$135
Bausch & Lomb, A Division Of Bausch Health US, LLC	1	$107
Topcon Healthcare, Inc.	2	$103
LKC Technologies, Inc.	1	$59
Kala Pharmaceuticals, Inc.	1	$34
Carl Zeiss Meditec, Inc.	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$88,172 in reported general payments places this provider in the 95th percentile of 33 corneal and contact management providers in Colorado.

See all corneal and contact management providers in Colorado →

Other corneal and contact management in Westminster

Rikard OlsonWestminster$2K
John SchachetCentennial$8K
Natalie SantelliFort Collins$5K
Sarah BellParker$4K
Grant SchanemanJohnstown$4K
Kevin AndersonFt Collins$2K
Jerry BellParker$2K
Larry EklundWellington$2K
Ting ZhangDenver$2K
C RoffisLouisville$1K

See the full list for Colorado →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →